Endocrine Metabolic & Immune Disorders-Drug Targets

简称 ENDOCR METAB IMMUNE ·U ARAB EMIRATES ·年均收录 22 篇

2.0

最新影响因子

1.30%

自引率

投稿难度

期刊简介

Endocrine Metabolic & Immune Disorders-Drug Targets是一本专注于内分泌代谢和免疫系统药物靶点研究的国际期刊，ISSN号为1871-5303，由Bentham Science出版社出版，出版地为阿拉伯联合酋长国，出版周期为双月刊。该期刊的影响因子根据年份有所不同，最新数据需查询官方来源，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区情况需根据最新分区表确认。其发文特点集中于内分泌疾病、代谢紊乱和免疫相关疾病的药物靶点发现、机制研究及治疗策略，涵盖基础与临床研究。杂志质量中等，审稿流程较为严格，但需注意其影响因子波动及投稿周期可能较长的风险，适合相关领域研究者投稿。

影响因子趋势

近期发表

Survey of Antibiotic Resistance of Acinetobacter Baumannii and Pseudomonas Aeruginosa at Ninh Thuan Province General Hospital in Vietnam in 2023 2026-09-14

Assessing the Effects of Childhood and Adult Body Mass Index on Diabetic Retinopathy Risk: A Mendelian Randomization Study 2026-09-11

Network Pharmacology and Molecular Docking Reveal the Multi-Target Anti-Osteoporosis Mechanism of Bushen Huoxue Decoction 2025-10-15

Exploring Effects of Propolis on Oral Mucositis in Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis 2025-04-08

Pseudoexfoliation Glaucoma Selective Laser for Trabeculoplasty Treatment in Vietnam 2025-10-15

Functions of Estrogen and Estrogen-Related Receptors in Diseases of the Female Reproductive System 2025-10-15

Current Insights into the Phytochemistry, Traditional, and Biological Importance of Matricaria pubescens (Desf.) Schultz 2026-09-05

The Food Paradox: Converting Foreign Matter into Self 2026-08-30

Exploring the Genetic Link between Irritable Bowel Syndrome and Polycystic Ovary Syndrome: Bidirectional Mendelian Randomization and Machine Learning Approaches 2025-04-18

Exploring and Validating Prognostic Biomarkers Related to Sphingolipid Metabolism in Gastric Cancer through Machine Learning 2025-05-05